Search
Patexia Research
Case number 1:22-cv-04620

AltaThera Pharmaceuticals LLC v. Hyloris Pharmaceuticals SA et al > Documents

Date Field Doc. No.PartyDescription
Nov 30, 2022 0 MOTION by Defendant Hyloris Pharmaceuticals SA for leave to file Hyloris Pharmaceuticals SA's Unopposed, Renewed Motion for Leave to File a Supplemental Brief in Further Support of its Motion to Dismiss (Attachments: # 1 Exhibit)(Rauchwerger, Dean) (Entered: 11/30/2022) (Exhibit) Download
Nov 30, 2022 50 MINUTE entry before the Honorable Sheila M. Finnegan: Magistrate Judge telephone status hearing held on 11/30/2022. Plaintiff issued Rule 26(a)(1) disclosures and written discovery on 11/15/2022. Defendants need not respond at this time. Defendants are to issue written discovery by 12/14/2022. By 12/20/2022, the parties are to confer regarding the written discovery and attempt to reach agreement on proceeding with some or all of that discovery. They are to file a joint status report by 12/23/2022 regarding their respective positions and any agreements reached, and any other updates that may bear on discovery issues. Telephone status hearing is set on 1/5/2023 at 11:00 a.m. The toll-free number for the next hearing is 877-336-1831, access code 5995354. Persons granted remote access to proceedings are reminded of the prohibition against recording and rebroadcasting of court proceedings. Mailed notice (sxw) (Entered: 11/30/2022) Download
Nov 30, 2022 49 MOTION by Defendant Hyloris Pharmaceuticals SA to seal document Hyloris Pharmaceuticals SA's Unopposed Motion to Place Under Seal Exhibit 46-1 to Motion for Leave (Dkt. 46) Filed on November 23, 2022 (Rauchwerger, Dean) (Entered: 11/30/2022) Download
Nov 30, 2022 48 MOTION by Defendant Hyloris Pharmaceuticals SA for leave to file Hyloris Pharmaceuticals SA's Unopposed, Renewed Motion for Leave to File a Supplemental Brief in Further Support of its Motion to Dismiss (Attachments: # 1 Exhibit)(Rauchwerger, Dean) (Entered: 11/30/2022) (Main Document) Download
Nov 28, 2022 47 MINUTE entry before the Honorable Franklin U. Valderrama: The Court denies Defendant Hyloris Pharmaceuticals Sa's Motion for Leave to File a Supplemental Brief in Further Support of its Motion to Dismiss 46 without prejudice because Defendant has failed to indicate in the title and the body of the motion whether the motion is opposed or unopposed. Pursuant to the Court's Standing Order, "[b]efore filing a motion, the movant's counsel must ask opposing counsel whether there is an objection to the motion. Whether the motion is opposed or unopposed should be so identified in the title and body of the motion." By 12/05/2022, Defendant may file another motion for leave to file a supplemental brief in further support of its motion to dismiss, and in that motion, Defendant must indicate in the title and the body of the motion whether the motion is opposed or unopposed. Mailed notice (axc). (Entered: 11/28/2022) Download
Nov 23, 2022 46 MOTION by Defendant Hyloris Pharmaceuticals SA for leave to file a Supplemental Brief in Further Support of its Motion to Dismiss (Attachments: # 1 Exhibit)(Rauchwerger, Dean) (Entered: 11/23/2022) Download
Nov 22, 2022 45 MINUTE entry before the Honorable Sheila M. Finnegan: Magistrate Judge telephone status is set on 11/30/2022 at 10:15 a.m. The toll-free number for the next hearing is 877-336-1831, access code 5995354. Persons granted remote access to proceedings are reminded of the prohibition against recording and rebroadcasting of court proceedings. Mailed notice (sxw) (Entered: 11/22/2022) Download
Nov 16, 2022 44 EXECUTIVE COMMITTEE ORDER:Case referred to the Honorable Sheila M. Finnegan for Discovery Motions, Discovery Supervision, Discovery Conference under Rule 26(f), and Settlement Conference. Signed by Executive Committee on 11/16/22. (aee, ) (Entered: 11/17/2022) Download
Nov 15, 2022 43 MINUTE entry before the Honorable Franklin U. Valderrama: This matter is sent to the Executive Committee for a referral on discovery supervision (including setting all deadlines, resolution of any discovery motion, and resolution of any motion to stay discovery) and settlement matters to a newly assigned Magistrate Judge. Mailed notice (axc). (Entered: 11/15/2022) Download
Nov 14, 2022 0 Notice re Service of Process on Hyloris Pharmaceuticals SA by AltaThera Pharmaceuticals LLC (Attachments: # 1 Exhibit)(Horowitz, Steven) (Entered: 11/14/2022) (Exhibit) Download
Nov 14, 2022 42 STATUS Report Joint Initial Status Report Under Rule 26(f) by AltaThera Pharmaceuticals LLC (Horowitz, Steven) (Entered: 11/14/2022) Download
Nov 14, 2022 41 Notice re Service of Process on Hyloris Pharmaceuticals SA by AltaThera Pharmaceuticals LLC (Attachments: # 1 Exhibit)(Horowitz, Steven) (Entered: 11/14/2022) (Main Document) Download
Nov 8, 2022 40 REPLY by Defendants Academic Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, John C. Somberg Defendants' Joint Reply in Support of Their Motions to Dismiss (Rauchwerger, Dean) (Entered: 11/08/2022) Download
Oct 26, 2022 39 MINUTE entry before the Honorable Franklin U. Valderrama: For the reasons stated in the motion, Plaintiff AltaThera Pharmaceuticals LLC's unopposed motion for leave to file its opposition to defendants' motions to dismiss under seal 37 is granted. Mailed notice (axc). (Entered: 10/26/2022) Download
Oct 25, 2022 0 RESPONSE by AltaThera Pharmaceuticals LLC to SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint 31 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim 26 (Redacted Version) (Attachments: # 1 Declaration of Jillian Sheridan Stonecipher, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Stonecipher, Jillian) (Entered: 10/25/2022) (Exhibit C) Download
Oct 25, 2022 0 RESPONSE by AltaThera Pharmaceuticals LLC to SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint 31 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim 26 (Redacted Version) (Attachments: # 1 Declaration of Jillian Sheridan Stonecipher, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Stonecipher, Jillian) (Entered: 10/25/2022) (Exhibit B) Download
Oct 25, 2022 0 RESPONSE by AltaThera Pharmaceuticals LLC to SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint 31 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim 26 (Redacted Version) (Attachments: # 1 Declaration of Jillian Sheridan Stonecipher, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Stonecipher, Jillian) (Entered: 10/25/2022) (Exhibit A) Download
Oct 25, 2022 0 RESPONSE by AltaThera Pharmaceuticals LLC to SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint 31 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim 26 (Redacted Version) (Attachments: # 1 Declaration of Jillian Sheridan Stonecipher, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Stonecipher, Jillian) (Entered: 10/25/2022) (Declaration of Jillian Sheridan Stonecipher) Download
Oct 25, 2022 38 SEALED RESPONSE by AltaThera Pharmaceuticals LLC to SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint 31 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim 26 (Attachments: # 1 Declaration of Jillian Sheridan Stonecipher, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Stonecipher, Jillian) (Entered: 10/25/2022) Download
Oct 25, 2022 37 MOTION by Plaintiff AltaThera Pharmaceuticals LLC to seal (Unopposed motion for leave to file its opposition to defendants' motions to dismiss under seal) (Stonecipher, Jillian) (Entered: 10/25/2022) Download
Oct 25, 2022 36 RESPONSE by AltaThera Pharmaceuticals LLC to SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint 31 , MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim 26 (Redacted Version) (Attachments: # 1 Declaration of Jillian Sheridan Stonecipher, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Stonecipher, Jillian) (Entered: 10/25/2022) (Main Document) Download
Oct 20, 2022 35 MINUTE entry before the Honorable Franklin U. Valderrama: For the reasons stated in the motion, Defendant Hyloris Pharmaceuticals SA's unopposed motion for leave to file under seal 34 is granted. Defendant's unredacted motion to dismiss, supporting declaration, and two exhibits to the motion to dismiss 31 may remain under seal. Defendant has already filed a redacted version 32 . Because R. 32 is simply the redacted version of the sealed motion to dismiss R. 31 , the Clerk is instructed to terminate R. 32 as a motion. Mailed notice (axc). (Entered: 10/20/2022) Download
Oct 14, 2022 34 MOTION by Defendant Hyloris Pharmaceuticals SA for leave to file Unopposed Motion for Leave to File Exhibits Under Seal (Rauchwerger, Dean) (Entered: 10/14/2022) Download
Oct 13, 2022 33 MINUTE Entry before the Honorable Franklin U. Valderrama: The Court denies Defendant Hyloris Pharmaceuticals SA's motion for leave to file exhibits under seal 30 without prejudice because Defendant's counsel has failed to indicate in the title and the body of the motion whether the motion is opposed or unopposed. Pursuant to the Court's Standing Order, "[b]efore filing a motion, the movant's counsel must ask opposing counsel whether there is an objection to the motion. Whether the motion is opposed or unopposed should be so identified in the title and body of the motion." Defendant may file another motion for leave file under seal on or before 10/17/2022 and in that motion Defendant's counsel must indicate in the title and the body of the motion whether the motion is opposed or unopposed. The sealed motion 31 may provisionally remain under seal pending the Court's ruling on Defendant's renewed motion for leave to file under seal. Mailed notice (axc). (Entered: 10/13/2022) Download
Oct 6, 2022 0 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendant Hyloris Pharmaceuticals SA And On Other Grounds (Attachments: # 1 Declaration)(Rauchwerger, Dean) (Entered: 10/06/2022) (Declaration) Download
Oct 6, 2022 32 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendant Hyloris Pharmaceuticals SA And On Other Grounds (Attachments: # 1 Declaration)(Rauchwerger, Dean) (Entered: 10/06/2022) (Main Document) Download
Oct 6, 2022 31 SEALED MOTION by Defendant Hyloris Pharmaceuticals SA To Dismiss Complaint (Attachments: # 1 Declaration)(Rauchwerger, Dean) (Entered: 10/06/2022) Download
Oct 6, 2022 30 MOTION by Defendant Hyloris Pharmaceuticals SA For Leave To File Exhibits Under Seal (Rauchwerger, Dean) (Entered: 10/06/2022) Download
Oct 4, 2022 28 MINUTE entry before the Honorable Franklin U. Valderrama: The Court sets the following briefing schedule on Defendants Academic Pharmaceuticals Inc. and John C. Somberg's Motion to Dismiss For Improper Venue and Failure to State A Claim 26 : Plaintiff's response due by 10/25/2022; Defendants' reply due by 11/8/2022. Mailed notice (axc). (Entered: 10/04/2022) Download
Oct 4, 2022 27 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19906407. (Jones, Keith) (Entered: 10/04/2022) Download
Oct 4, 2022 29 MINUTE entry before the Honorable Franklin U. Valderrama: Attorney Keith A. Jones's motion for leave to appear pro hac vice 27 is granted. Mailed notice (axc). (Entered: 10/04/2022) Download
Oct 3, 2022 26 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim (Attachments: # 1 Exhibit Declaration)(Rauchwerger, Dean) (Entered: 10/03/2022) (Main Document) Download
Oct 3, 2022 25 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Academic Pharmaceuticals Inc. LR 3.2 Notification to Affiliates and Rule 7.1 Disclosure Statement (Rauchwerger, Dean) (Entered: 10/03/2022) Download
Oct 3, 2022 24 ATTORNEY Appearance for Defendants Academic Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, John C. Somberg by Dean Scott Rauchwerger (Rauchwerger, Dean) (Entered: 10/03/2022) Download
Oct 3, 2022 23 ATTORNEY Appearance for Defendants Academic Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, John C. Somberg by Jonathan Kevin Barger (Barger, Jonathan) (Entered: 10/03/2022) Download
Oct 3, 2022 22 MINUTE entry before the Honorable Franklin U. Valderrama: Attorney Erin Marie Dunston's motion for leave to appear pro hac vice 21 is granted. Mailed notice (axc). (Entered: 10/03/2022) Download
Oct 3, 2022 21 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19903393. (Dunston, Erin) (Entered: 10/03/2022) Download
Oct 3, 2022 20 MINUTE entry before the Honorable Franklin U. Valderrama: Attorney Philip L. Hirschhorn's motion for leave to appear pro hac vice 19 is granted. Mailed notice (axc). (Entered: 10/03/2022) Download
Oct 3, 2022 0 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Academic Pharmaceuticals Inc., John C. Somberg Motion to Dismiss For Improper Venue and Failure to State A Claim (Attachments: # 1 Exhibit Declaration)(Rauchwerger, Dean) (Entered: 10/03/2022) (Exhibit Declaration) Download
Oct 2, 2022 19 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19900792. (Hirschhorn, Philip) (Entered: 10/02/2022) Download
Sep 29, 2022 18 ATTORNEY Appearance for Plaintiff AltaThera Pharmaceuticals LLC by Thomas Aaron Weber (Weber, Thomas) (Entered: 09/29/2022) Download
Sep 26, 2022 17 SUMMONS Returned Executed by AltaThera Pharmaceuticals LLC as to Hyloris Pharmaceuticals SA on 9/15/2022, answer due 10/6/2022. (Horowitz, Steven) (Entered: 09/26/2022) Download
Sep 26, 2022 16 SUMMONS Returned Executed by AltaThera Pharmaceuticals LLC as to Academic Pharmaceuticals Inc. on 9/12/2022, answer due 10/3/2022. (Horowitz, Steven) (Entered: 09/26/2022) Download
Sep 26, 2022 15 SUMMONS Returned Executed by AltaThera Pharmaceuticals LLC as to John C. Somberg on 9/12/2022, answer due 10/3/2022. (Horowitz, Steven) (Entered: 09/26/2022) Download
Sep 13, 2022 0 MAILED Summons and Complaint to Hyloris Pharmaceuticals SA via FedEx (8994 5120 8575.) (lw, ) (Entered: 09/13/2022) Download
Sep 12, 2022 0 SUMMONS Issued as to Defendants Academic Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, John C. Somberg (emc, ) (Entered: 09/12/2022) Download
Sep 2, 2022 13 MINUTE entry before the Honorable Franklin U. Valderrama: Attorney Lauren Cranford Katzeff's motion for leave to appear pro hac vice 12 is granted. Mailed notice (axc). (Entered: 09/02/2022) Download
Sep 2, 2022 14 ATTORNEY Appearance for Plaintiff AltaThera Pharmaceuticals LLC by Lauren C. Katzeff (Katzeff, Lauren) (Entered: 09/02/2022) Download
Sep 1, 2022 12 MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-19801267. (Katzeff, Lauren) (Entered: 09/01/2022) Download
Aug 31, 2022 11 MAILED patent report to Patent Trademark Office, Alexandria VA. (aee, ) (Entered: 08/31/2022) Download
Aug 31, 2022 10 MINUTE entry before the Honorable Franklin U. Valderrama: On or before 11/14/2022 the parties shall file a joint initial status report. A template for the Joint Initial Status Report, setting forth the information required, may be found at http://www.ilnd.uscourts.gov/Judges.aspx by clicking on Judge Valderrama's name and then again on the link entitled 'Joint Initial Status Report. Plaintiff must serve this Minute Entry on all other parties. If the defendant(s) has not been served with process by that date, plaintiff's counsel is instructed to file an individual status report indicating the status of service of process by the same deadline. The parties are further ordered to review all of Judge Valderrama's standing orders and the information available on his webpage. Any nongovernmental corporate party that qualifies under the Rules is reminded of the requirement to file a disclosure statement under Federal Rule of Civil Procedure 7.1/N.D. Ill. Local Rule 3.2. Mailed notice (axc). (Entered: 08/31/2022) Download
Aug 31, 2022 9 MINUTE entry before the Honorable Franklin U. Valderrama: For the reasons stated in the motion, Plaintiff's motion for leave to file its complaint under seal 6 is granted. Mailed notice (axc). (Entered: 08/31/2022) Download
Aug 30, 2022 8 Report on Filing Determination of an Action Regarding a Patent or Trademark by AltaThera Pharmaceuticals LLC (Horowitz, Steven) (Entered: 08/30/2022) Download
Aug 30, 2022 7 SEALED DOCUMENT by Plaintiff AltaThera Pharmaceuticals LLC - Sealed Complaint (Horowitz, Steven) (Entered: 08/30/2022) Download
Aug 30, 2022 6 MOTION by Plaintiff AltaThera Pharmaceuticals LLC to seal (Horowitz, Steven) (Entered: 08/30/2022) Download
Aug 30, 2022 0 CLERK'S NOTICE: Pursuant to Local Rule 73.1(b), a United States Magistrate Judge of this court is available to conduct all proceedings in this civil action. If all parties consent to have the currently assigned United States Magistrate Judge conduct all proceedings in this case, including trial, the entry of final judgment, and all post-trial proceedings, all parties must sign their names on the attached Consent To form. This consent form is eligible for filing only if executed by all parties. The parties can also express their consent to jurisdiction by a magistrate judge in any joint filing, including the Joint Initial Status Report or proposed Case Management Order. (kra, ) (Entered: 08/30/2022) Download
Aug 30, 2022 0 CASE ASSIGNED to the Honorable Franklin U. Valderrama. Designated as Magistrate Judge the Honorable M. David Weisman. Case assignment: Random assignment. (kra, ) (Entered: 08/30/2022) Download
Aug 30, 2022 5 ATTORNEY Appearance for Plaintiff AltaThera Pharmaceuticals LLC by Jillian Sheridan Stonecipher (Stonecipher, Jillian) (Entered: 08/30/2022) Download
Aug 30, 2022 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by AltaThera Pharmaceuticals LLC (Horowitz, Steven) (Entered: 08/30/2022) Download
Aug 30, 2022 3 ATTORNEY Appearance for Plaintiff AltaThera Pharmaceuticals LLC by Steven Joseph Horowitz (Horowitz, Steven) (Entered: 08/30/2022) Download
Aug 30, 2022 2 CIVIL Cover Sheet (Horowitz, Steven) (Entered: 08/30/2022) Download
Aug 30, 2022 1 COMPLAINT (REDACTED) filed by AltaThera Pharmaceuticals LLC; Yes. Filing fee $ 402, receipt number AILNDC-19792445.(Horowitz, Steven) (Docket Text Modified by Clerk's Office). Modified on 8/30/2022 (jmk, ). (Entered: 08/30/2022) Download
Menu